Trending
UK High Yield Income Fund with 10% p.a. | Secured & Insured Debt | Low Correlation to Traditional Asset Classes
Sequince Capital operates the UK High Yield Income Fund, an Australian-domiciled fund targeting an annual income yield to investors of 10% net of fees, with quarterly income distributions, while seeki
AEGROS – GREAT NEWS AND A GREAT LEAP FORWARD
In the interview and in the attached summary, Professor Nair explains why risks in the second arm of the clinical trial are low and should give comfort to early-stage investors in Aegros.
B2B deeptech company with Innovate UK grant raising £400K in common stock under SEIS/EIS
MatLogica is looking to raise £400,000 in common stock under SEIS/EIS through to December 2022.
Sunshine Hydro formalises MoU with new partners | Appoints new VP Sales & Business Development
Sunshine Hydro has announced recent company developments. Sunshine Hydro partnered and formalised a Memorandum of Understanding with Gidarjil Development Corporation and Burnett Mary Regional Group
Nurse extraordinaire and social entrepreneur wins prestigious award
Yangama Jokwiro received the prestigious Best Workforce and Industry Development Initiative Award.
Chip Tyre – Investor Presentation Brisbane Capital Showcase
Chip Tyre (in conjunction with BioAust Energy) have, under the Blew Chip banner, developed a new system of producing and delivering ANFO style explosives for major mining through to small-scale earth moving. The new system is highly suited to large-scale mining and it delivers environmental benefits that will impress environmentalists and governments around the world. […]
VICTORIAN GOVERNMENT BACKS STUDY INTO SITE FOR ZERO-EMISSIONS MAGNESIUM PROCESSING
The Victorian government has announced an unspecified amount of support for a feasibility study into a site to make up to 120 kilotons a year of magnesium using a process developed at the CSIRO.
Fintech company surviving a market crash and achieving over 13% returns year to date
We have now reached over a full 12 months of business operating in Australia and we are proud to be consistently still delivering returns for our clients. In 2020 so far we have seen a terrible…
EpiAxis Therapeutics & Peter Thiel-backed Peptilogics Enter Strategic Partnership
EpiAxis Therapeutics and computational biology company Peptilogics have entered a collaboration to leverage AI for drug discovery.
Backed By Leading Investment Groups and Family Offices
